HIV/AIDS
RSSArticles
-
Direct-acting antivirals for hepatitis C show promise
Gane et al conducted a randomized open label trial of 40 patients with HCV genotype 2 or 3 infection which evaluated sofosbuvir 400 mg once daily plus ribavirin (RBV) for 12 weeks. -
Updates
Saint S, et al, Perceived strength of evidence supporting best practices to prevent health care-associated infection: results from a national survey of infection prevention personnel. Am J Infect Control 2013;(41):100-106. -
Pharmacology Watch: Aspirin Use and Age-Related Macular Degeneration
In this issue: Aspirin use and AMD risk; using NSAIDs and antihypertensive agents; and FDA actions. -
Clinical Briefs in Primary Care supplement
-
Malaria Continues to Take Staggering Toll as Relief Efforts Plateau
It is estimated that there were approximately 219 million cases of malaria in the world in 2010 and 680,000 or these cases were fatal. The majority of deaths occur in children, most in Africa — with one dying every minute. Fourteen countries are estimated to account for 80% of deaths, with the Democratic Republic of the Congo and Nigeria accounting for 40% of total global malaria deaths. -
STD Quarterly-Take control during National HIV Testing Day
-
Infection guidelines reach beyond hospital
-
JCAHO defines surgical complications measures
-
FDA action may clear way for more reprocessing
-
Call to action: ICPs must take leadership role in patient safety movement